SHC Sotera Health Co
Services-Misc Health & Allied Services, NEC · Nasdaq · SEC CIK 1822479 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.9%
TTM net income YoY213.0%
TTM EPS YoY200.0%
Revenue 3-yr CAGR7.5%
Net income 3-yr CAGR—
Margins
Gross margin54.6%
Operating margin—
Net margin14.1%
FCF margin11.0%
EBITDA margin—
Returns
ROE27.0%
ROA5.3%
ROIC (approx.)—
Asset turnover0.37x
Leverage & solvency
Liabilities / assets78.4%
Debt / equity2.91x
Current ratio3.13x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.91x
Accruals ratio-4.8%
Payout ratio—
Capex / revenue16.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $1.16B | $1.10B |
| Cost of revenue | $518.08M | $498.15M |
| Gross profit | $645.53M | $602.29M |
| SG&A expense | $252.76M | $242.63M |
| Operating income | — | $297.63M |
| Pretax income | $147.51M | $113.87M |
| Income tax | $69.56M | $69.48M |
| Net income | $77.95M | $44.40M |
| EBITDA | — | $381.93M |
| EPS (basic) | 0.27 | 0.16 |
| EPS (diluted) | 0.27 | 0.16 |
| Weighted avg. shares (diluted) | 286.42M | 284.91M |
| Balance sheet | ||
| Cash & equivalents | $344.62M | $278.87M |
| Receivables | $139.33M | $140.33M |
| Inventory | $54.38M | $49.16M |
| Current assets | $613.41M | $526.04M |
| PP&E, net | $1.13B | $1.04B |
| Goodwill | $1.10B | $1.08B |
| Intangibles | $288.23M | $317.65M |
| Total assets | $3.26B | $3.07B |
| Current liabilities | $249.58M | $191.00M |
| Short-term debt | $13.97M | $14.80M |
| Long-term debt | $2.13B | $2.21B |
| Total debt | $2.14B | $2.22B |
| Total liabilities | $2.66B | $2.67B |
| Shareholders' equity | $606.03M | $404.91M |
| Net debt | $1.80B | $1.94B |
| Cash flow statement | ||
| Operating cash flow | $287.19M | $224.16M |
| Capital expenditure | $138.02M | $179.07M |
| Free cash flow | $149.18M | $45.09M |
| Investing cash flow | -$135.14M | -$179.00M |
| Financing cash flow | -$100.53M | -$50.56M |
| Depreciation & amortization | $94.90M | $84.30M |
| Stock-based compensation | $30.88M | $36.78M |
Free plan shows the latest 2 periods; Pro shows all 7 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.